Step Forward into New Growth

Today’s market is moving faster than ever. To stay on top of consumer trends, be one step ahead of the competition and propel bottom line growth, Albertsons needs relevant insights to help enable innovation. As part of the Step Forward with IRI Thought Leadership program, leaders from IRI will provide unique perspectives on your biggest business issues and give you practical tips on leveraging world-class insights and analytics. These sessions are designed to stimulate ideas around new growth opportunities for Albertsons.

2018 “STEP FORWARD” SESSIONS

Leveraging Drug Channel Insights for Albertsons’ Growth

July 10, 2:30 p.m. – 3:30 p.m. MDT
(Boise, ID) 
 -OR-
July 11, 9 a.m. – 10 a.m. PDT
(Pleasanton, CA)
The recent announcement of the upcoming potential merger of Rite Aid and Albertsons is driving new discussions around the evolution of consumers and shoppers across the drug and grocery channels. Retail consumer behavior is changing due to social media influence and the shift to a more convenient, dynamic purchase landscape. Both the drug and grocery channels are impacted by these changes, making it even more important for Albertsons to be aware of the opportunities and challenges ahead. This session will take a closer look at:
  • The factors that are driving disruption at retail
  • Challenges in the drug channel

SPEAKER
 
Robert Sanders, EVP, Home & Healthcare Practice Leader, IR

Robert (Bob) Sanders brings more than 30 years of experience to the marketplace and is responsible for cultivating and building global partnerships with IRI’s clients. In his current role, Bob sets the strategic initiatives for IRI’s home and healthcare practice by identifying business opportunities, delivering insights and making actionable recommendations critical for winning in the market. He leads teams of seasoned insights and consulting professionals with extensive expertise in CPG/HBA, Nutritionals and home-related categories.

Bob is a senior executive with a strong general management and consultative background. Before joining IRI in 2008, he held executive positions with Wyeth/Pfizer Whitehall-Robins and Lederle Consumer Health in sales, marketing and general management capacities. As the senior vice president of Sales at Wyeth, he managed direct, broker and medical sales teams. As SVP/General Manager for nine years focused on developing global brand strategies, Bob and his team drove sales, share and profitability growth year over year.

Bob graduated from William Paterson University and has an MBA from the University of Scranton. He also holds a certificate from the Columbia Executive Program and is a Certified Public Accountant (CPA).